US Patent Issued to The Board of Trustees of the University of Illinois on Aug. 19 for "Multi-chimeric cell and therapy for transplantation and treatment of immune deficiencies and genetic disorders" (Illinois Inventor)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,927, issued on Aug. 19, was assigned to The Board of Trustees of the University of Illinois (Urbana, Ill.).

"Multi-chimeric cell and therapy for transplantation and treatment of immune deficiencies and genetic disorders" was invented by Maria Siemionow (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "A multi-chimeric cell created by ex vivo fusion of three or more hematopoietic stem cells, mesenchymal stem cells, myoblasts, pericytes, or satellite cells, or a combination thereof, from three or more different donors is provided, as is the use of these cells in transplant therapy and treatment of immune deficiency and genetic disorders."

The p...